GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » ViaDerma Inc (OTCPK:VDRM) » Definitions » ROIC %

ViaDerma (ViaDerma) ROIC % : 10.58% (As of Jun. 2012)


View and export this data going back to 2008. Start your Free Trial

What is ViaDerma ROIC %?

ROIC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROC %. ViaDerma's annualized return on invested capital (ROIC %) for the quarter that ended in Jun. 2012 was 10.58%.

As of today (2024-05-25), ViaDerma's WACC % is 0.00%. ViaDerma's ROIC % is 0.00% (calculated using TTM income statement data). ViaDerma earns returns that do not match up to its cost of capital. It will destroy value as it grows.


ViaDerma ROIC % Historical Data

The historical data trend for ViaDerma's ROIC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ViaDerma ROIC % Chart

ViaDerma Annual Data
Trend Dec07 Dec08 Dec09 Dec10 Dec11
ROIC %
-1,762.50 69.08 18.91 18.22 8.26

ViaDerma Quarterly Data
Sep07 Dec07 Mar08 Jun08 Sep08 Dec08 Mar09 Jun09 Sep09 Dec09 Mar10 Jun10 Sep10 Dec10 Mar11 Jun11 Sep11 Dec11 Mar12 Jun12
ROIC % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 13.27 5.24 6.68 5.30 10.58

Competitive Comparison of ViaDerma's ROIC %

For the Drug Manufacturers - Specialty & Generic subindustry, ViaDerma's ROIC %, along with its competitors' market caps and ROIC % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


ViaDerma's ROIC % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, ViaDerma's ROIC % distribution charts can be found below:

* The bar in red indicates where ViaDerma's ROIC % falls into.



ViaDerma ROIC % Calculation

ViaDerma's annualized Return on Invested Capital (ROIC %) for the fiscal year that ended in Dec. 2011 is calculated as:

ROIC % (A: Dec. 2011 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (A: Dec. 2010 ) + Invested Capital (A: Dec. 2011 ))/ count )
=4.039 * ( 1 - 24.64% )/( (33.054 + 40.658)/ 2 )
=3.0437904/36.856
=8.26 %

where

ViaDerma's annualized Return on Invested Capital (ROIC %) for the quarter that ended in Jun. 2012 is calculated as:

ROIC % (Q: Jun. 2012 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Mar. 2012 ) + Invested Capital (Q: Jun. 2012 ))/ count )
=6.084 * ( 1 - 28.75% )/( (40.786 + 41.193)/ 2 )
=4.33485/40.9895
=10.58 %

where

Note: The Operating Income data used here is four times the quarterly (Jun. 2012) data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


ViaDerma  (OTCPK:VDRM) ROIC % Explanation

ROIC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROC %. The reason book values of debt and equity are used is because the book values are the capital the company received when issuing the debt or receiving the equity investments.

There are four key components to this definition. The first is the use of operating income or EBIT rather than net income in the numerator. The second is the tax adjustment to this operating income or EBIT, computed as a hypothetical tax based on an effective or marginal tax rate. The third is the use of book values for invested capital, rather than market values. The final is the timing difference; the capital invested is from the end of the prior year whereas the operating income or EBIT is the current year's number.

Why is ROIC % important?

Because it costs money to raise capital. A firm that generates higher returns on investment than it costs the company to raise the capital needed for that investment is earning excess returns. A firm that expects to continue generating positive excess returns on new investments in the future will see its value increase as growth increases, whereas a firm that earns returns that do not match up to its cost of capital will destroy value as it grows.

As of today, ViaDerma's WACC % is 0.00%. ViaDerma's ROIC % is 0.00% (calculated using TTM income statement data).


Be Aware

Like ROE % and ROA %, ROIC % is calculated with only 12 months of data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.


ViaDerma ROIC % Related Terms

Thank you for viewing the detailed overview of ViaDerma's ROIC % provided by GuruFocus.com. Please click on the following links to see related term pages.


ViaDerma (ViaDerma) Business Description

Traded in Other Exchanges
N/A
Address
4640 Admiralty Way, Suite 500, Marina Del Rey, CA, USA, 90292
ViaDerma Inc is a specialty pharmaceutical company focused to bring new products to market through research and development. It is engaged in the business of manufacturing and sales of pharmaceuticals, and specifically topical antibiotics and pain management in the United States of America. Its sells under the brand name Vitastem. The Company also has products in development in the fields; anti-aging skin care, pain management, hair-loss, and toenail fungus.